Iran Conflict: A Looming Shadow Over Pharmaceutical Supply Chains The recent escalation of conflict in the Middle East hasn’t yet caused widespread disruption to global pharmaceutical supplies, but experts warn that the potential for significant impact is growing. While current production in the immediate conflict zone represents a minor fraction of global output – just … Read more
CNBC Cures: A Turning Tide for Rare Disease Awareness and Innovation The launch of CNBC Cures, spearheaded by Becky Quick and her sister, marks a significant shift in how rare diseases are discussed and addressed. What began as a personal mission – driven by Quick’s own family’s experience with a rare disease diagnosis – has … Read more
Lilly’s Retatrutide: A New Era in Diabetes and Weight Management? Eli Lilly’s investigational drug, retatrutide, is generating significant buzz after demonstrating impressive results in a late-stage trial for Type 2 diabetes. The findings, released today, suggest a potential breakthrough in managing both blood sugar and weight – a historically challenging combination for individuals with the … Read more
Cancer Immunotherapy: A New Target Emerges as Cells ‘Barf’ Proteins Researchers have identified a surprising location for a key protein, Src, on the surface of cancer cells – a place it shouldn’t be. This discovery, reported in Science, could unlock new avenues for immunotherapy, particularly for solid tumors, which have historically been hard to treat … Read more
Immunotherapy Plateau? New Data Shifts Focus Back to Radiation in Small Cell Lung Cancer A recent international clinical trial, NRG-LU005, has delivered a nuanced message in the fight against limited-stage small cell lung cancer (LS-SCLC). While the addition of immunotherapy drug atezolizumab to standard chemoradiation didn’t significantly improve overall survival, a surprising trend emerged: twice-daily … Read more
FDA Vaccine Chief’s Exit Signals a Potential Shift in Regulatory Scrutiny The recent departure of Dr. Vinay Prasad, the Food and Drug Administration’s (FDA) vaccine chief, marks a potentially significant moment for the agency and the pharmaceutical industry. Prasad’s second exit from the FDA, confirmed on March 6, 2026, follows a period of controversial decisions … Read more
The AI Revolution in Cardiology: Beyond Diagnosis Cardiovascular disease remains a leading cause of death globally. But a recent wave of innovation, powered by deep learning and artificial intelligence, is poised to dramatically reshape how we understand, diagnose, and treat heart conditions. Recent advancements aren’t just about faster diagnoses; they’re about unlocking deeper insights into … Read more
Lilly’s New Playbook: Expanding Access to Obesity Drugs and Reshaping the Market Eli Lilly has launched “Employer Connect,” a new platform aimed at making its obesity drug, Zepbound, more accessible to employees through their health insurance. This move addresses a significant hurdle in the rapidly evolving obesity treatment landscape: cost and inconsistent employer coverage. Although … Read more
Moderna Reaches $2.25 Billion Settlement in COVID-19 Vaccine Patent Dispute Moderna has agreed to a substantial settlement, potentially reaching $2.25 billion, to resolve a patent conflict with Roivant Sciences and its subsidiaries, Genevant Sciences and Arbutus Biopharma. The dispute centered on the technology used to deliver Moderna’s mRNA-based COVID-19 vaccine. The Core of the Dispute: … Read more
Mushroom Power: Could Fungi Be the Future of Vaccine Effectiveness? Researchers at the University of California San Diego School of Medicine have uncovered a potentially groundbreaking link between medicinal mushrooms and improved vaccine response. A recent study, published in BMC Immunology on March 3, 2026, suggests a natural fungal supplement could be a game-changer in … Read more